Delays in diagnosis and melanoma prognosis (I): The role of patients
✍ Scribed by Marie A. Richard; Jean J. Grob; Marie F. Avril; Michèle Delaunay; Johany Gouvernet; Pierre Wolkenstein; Pierre Souteyrand; Brigitte Dreno; Jean J. Bonerandi; Sophie Dalac; Laurent Machet; Jean C. Guillaume; Jacqueline Chevrant-Breton; Catherine Vilmer; François Aubin; Bernard Guillot; Marie Beylot-Barry; Catherine Lok; Nadia Raison-Peyron; Philippe Chemaly
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 103 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
effective therapy is essential. This is best accomplished by identifying which of the hypoglycemic processes is involved, as treatments differ. Some patients present
We calculated the short-term and long-term risks of developing cancer among 3,766 patients with a diagnosis of cutaneous melanoma in situ in Sweden from 1958 to 1992. In total, 393 patients developed a primary cancer at any site compared with an expected number of 177 [standardized incidence ratio (